JPMorgan Chase Reduces Stake in Hinge Health

Institutional investor sells over 100,000 shares of digital healthcare company

Feb. 28, 2026 at 10:19am by Ben Kaplan

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has reduced its position in Hinge Health Inc. (NYSE:HNGE), a digital musculoskeletal clinic, by selling 103,089 shares during the third quarter. The institutional investor now owns 744,056 shares, representing a 12.2% decrease in its stake in the company.

Why it matters

This move by a major institutional investor like JPMorgan Chase could signal a shift in sentiment around Hinge Health, which provides digital solutions for musculoskeletal conditions. The sale may reflect broader market trends or changes in JPMorgan's investment strategy.

The details

According to a disclosure with the Securities & Exchange Commission, JPMorgan Chase sold the 103,089 shares of Hinge Health, reducing its total position to 744,056 shares. The investment firm now owns 0.95% of the company's stock, which was valued at $36.5 million at the end of the quarter.

  • JPMorgan Chase sold the shares during the third quarter of 2026.

The players

JPMorgan Chase & Co.

A multinational investment bank and financial services company headquartered in New York City.

Hinge Health Inc.

A digital musculoskeletal clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in JPMorgan Chase's stake in Hinge Health could signal a broader shift in investor sentiment around the digital healthcare company. However, Hinge Health remains a well-funded and growing player in the musculoskeletal care market.